https://dewpointx.com/dewpoint-therapeutics-announces-nomination-of-first-c-mod-development-candidate-dptx3186-for-treatment-of-wnt-driven-cancers/ The Biomolecular Condensates Company Mon, 28 Oct 2024 12:03:35 +0000 hourly 1